Edwards Lifesciences (NYSE: EW) CVP logs sale and major equity awards
Rhea-AI Filing Summary
Edwards Lifesciences Corp executive Wayne Markowitz, CVP, JAPAC, reported a mix of share sales and new equity awards. He completed an open-market sale of 593 shares of common stock at $79.73 per share on May 11, 2026, and held 21,679.8708 shares afterward.
On May 7, 2026, he received 5,200 restricted stock units and separate 5,200 performance-based restricted stock units under the Long-Term Stock Incentive Compensation Program, plus 26,400 employee stock options with a $82.76 exercise price, all vesting in installments starting one year after grant.
On May 7 and May 8, a total of 490 shares of common stock were disposed of as tax-withholding transactions related to equity compensation, rather than open-market sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 4,117 shares
Net Buy
6 txns
Insider
Markowitz Wayne
Role
CVP, JAPAC
Sold
593 shs ($47K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 593 | $79.73 | $47K |
| Exercise Price or Tax Liability | Common Stock | 226 | $82.76 | $19K |
| Grant/Award | Employee Stock Option (Right to Acquire) | 26,400 | $0.00 | $0.00 |
| Grant/Award | Performance Rights | 5,200 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 5,200 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 264 | $83.20 | $22K |
Holdings After Transaction:
Employee Stock Option (Right to Acquire) — 26,400 shares (Direct);
Performance Rights — 5,200 shares (Direct);
Common Stock — 21,679.8708 shares (Direct)
Footnotes (3)
- F1. These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
- F2. These options were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
- F3. Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards.
Key Figures
Open-market sale: 593 shares at $79.73
Post-transaction holdings: 21,679.8708 shares
Restricted stock units granted: 5,200 shares
+3 more
6 metrics
Open-market sale
593 shares at $79.73
Common stock sale on May 11, 2026
Post-transaction holdings
21,679.8708 shares
Common stock directly held after May 11, 2026 sale
Restricted stock units granted
5,200 shares
Time-based RSUs granted May 7, 2026
Performance RSU target award
5,200 shares, 0–200% possible
Vests May 7, 2029 based on three-year goals
Stock options granted
26,400 options at $82.76
Employee stock options granted May 7, 2026, expire 2033
Tax-withholding shares
490 shares
Shares disposed for tax obligations May 7–8, 2026
Key Terms
restricted stock units, Long-Term Stock Incentive Compensation Program, Performance Rights, Employee Stock Option (Right to Acquire), +2 more
6 terms
restricted stock units financial
"These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Long-Term Stock Incentive Compensation Program financial
"granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program"
Performance Rights financial
"security_title":"Performance Rights","transaction_date":"2026-05-07T00:00:00.000Z""
Performance rights are conditional awards that give employees or executives the promise of receiving company shares or cash only if the business meets specific targets or survives for a set period. They work like a bonus you only get when certain goals are hit, so they matter to investors because they can increase the number of shares outstanding (dilution), signal management’s incentives and confidence in future results, and affect per-share earnings and valuation.
Employee Stock Option (Right to Acquire) financial
"security_title":"Employee Stock Option (Right to Acquire)","transaction_date":"2026-05-07T00:00:00.000Z""
tax-withholding disposition financial
"transaction_action":"tax-withholding disposition","transaction_code_description":"Payment of exercise price or tax liability by delivering securities""
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
Target Award financial
"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Edwards Lifesciences (EW) report for Wayne Markowitz?
Wayne Markowitz reported an open-market sale of 593 common shares and several equity awards. He also had tax-withholding dispositions tied to compensation. After these transactions, he directly held 21,679.8708 shares of Edwards Lifesciences common stock.
What new equity awards did Wayne Markowitz receive from Edwards Lifesciences (EW)?
He received 5,200 restricted stock units, 5,200 performance-based restricted stock units, and 26,400 employee stock options with an $82.76 exercise price. These awards were granted under the company’s Long-Term Stock Incentive Compensation Program on May 7, 2026.
How do the performance-based restricted stock units for Edwards Lifesciences (EW) work?
The performance-based restricted stock units reflect a target 5,200-share award scheduled to vest on May 7, 2029. Actual vesting will depend on achieving three-year performance goals, and the payout can range from 0% to 200% of the target number of units.
What stock option grant did Wayne Markowitz receive from Edwards Lifesciences (EW)?
He was granted 26,400 employee stock options on May 7, 2026 with an exercise price of $82.76 per share. These options vest and become exercisable in four equal annual installments, beginning one year after the grant date and expiring in 2033.